| Number | GOID | Name | p-value | FDR(GOSSIP) | FWER(GOSSIP) | Holm | Sidak | BH | BY | Bonferoni |
| 1 | 4871 | signal transducer activity | 1.05e-06 | 0.0002 | 6.25e-05 | 0.0005 | 0.0005 | 0.0005 | 0.003 | 0.0005
|
| 2 | 5102 | receptor binding | 8.94e-06 | 0.001 | 0.0006 | 0.004 | 0.004 | 0.001 | 0.01 | 0.004
|
| 3 | 1664 | G-protein-coupled receptor binding | 1.01e-05 | 0.001 | 0.0009 | 0.005 | 0.005 | 0.001 | 0.01 | 0.005
|
| 4 | 7154 | cell communication | 1.39e-05 | 0.001 | 0.001 | 0.007 | 0.007 | 0.001 | 0.01 | 0.007
|
| 5 | 19838 | growth factor binding | 0.0001 | 0.01 | 0.01 | 0.06 | 0.06 | 0.01 | 0.09 | 0.06
|
| 6 | 42379 | chemokine receptor binding | 0.0002 | 0.01 | 0.02 | 0.11 | 0.10 | 0.01 | 0.09 | 0.11
|
| 7 | 8009 | chemokine activity | 0.0002 | 0.01 | 0.02 | 0.11 | 0.10 | 0.01 | 0.09 | 0.11
|
| 8 | 42056 | chemoattractant activity | 0.0002 | 0.01 | 0.02 | 0.11 | 0.10 | 0.01 | 0.09 | 0.11
|
| 9 | 7165 | signal transduction | 0.0003 | 0.01 | 0.03 | 0.16 | 0.14 | 0.01 | 0.12 | 0.16
|
| 10 | 6952 | defense response | 0.0007 | 0.02 | 0.07 | 0.40 | 0.33 | 0.03 | 0.23 | 0.41
|
| 11 | 7186 | G-protein coupled receptor protein signaling pathway | 0.0007 | 0.02 | 0.07 | 0.40 | 0.33 | 0.03 | 0.23 | 0.41
|
| 12 | 6955 | immune response | 0.0007 | 0.02 | 0.07 | 0.41 | 0.33 | 0.03 | 0.23 | 0.41
|
| 13 | 9887 | organogenesis | 0.001 | 0.02 | 0.08 | 0.52 | 0.40 | 0.04 | 0.28 | 0.53
|
| 14 | 17017 | MAP kinase phosphatase activity | 0.001 | 0.06 | 0.23 | 0.76 | 0.53 | 0.05 | 0.35 | 0.78
|
| 15 | 5125 | cytokine activity | 0.001 | 0.06 | 0.24 | 1 | 0.55 | 0.05 | 0.35 | 0.82
|
| 16 | 5615 | extracellular space | 0.001 | 0.06 | 0.25 | 0.89 | 0.59 | 0.05 | 0.35 | 0.92
|
| 17 | 5520 | insulin-like growth factor binding | 0.001 | 0.06 | 0.27 | 0.90 | 0.59 | 0.05 | 0.35 | 0.92
|
| 18 | 5576 | extracellular | 0.001 | 0.06 | 0.27 | 0.90 | 0.59 | 0.05 | 0.35 | 0.93
|
| 19 | 7166 | cell surface receptor linked signal transduction | 0.001 | 0.06 | 0.28 | 1 | 0.63 | 0.05 | 0.37 | 1
|
| 20 | 5194 | cell adhesion molecule activity | 0.002 | 0.06 | 0.29 | 1 | 0.65 | 0.05 | 0.37 | 1
|
| 21 | 9653 | morphogenesis | 0.002 | 0.07 | 0.33 | 1 | 0.76 | 0.07 | 0.48 | 1
|
| 22 | 9607 | response to biotic stimulus | 0.003 | 0.07 | 0.34 | 1 | 0.81 | 0.08 | 0.55 | 1
|
| 23 | 7155 | cell adhesion | 0.003 | 0.07 | 0.36 | 1 | 0.84 | 0.08 | 0.58 | 1
|
| 24 | 7218 | neuropeptide signaling pathway | 0.003 | 0.08 | 0.39 | 1 | 0.86 | 0.08 | 0.58 | 1
|
| 25 | 7517 | muscle development | 0.004 | 0.08 | 0.40 | 1 | 0.88 | 0.08 | 0.58 | 1
|
| 26 | 9987 | cellular process | 0.004 | 0.08 | 0.40 | 1 | 0.88 | 0.08 | 0.58 | 1
|
| 27 | 6937 | regulation of muscle contraction | 0.004 | 0.11 | 0.53 | 1 | 0.88 | 0.08 | 0.58 | 1
|
| 28 | 7275 | development | 0.005 | 0.12 | 0.58 | 1 | 0.94 | 0.10 | 0.74 | 1
|
| 29 | 50789 | regulation of biological process | 0.005 | 0.12 | 0.59 | 1 | 0.95 | 0.10 | 0.74 | 1
|
| 30 | 4872 | receptor activity | 0.007 | 0.14 | 0.65 | 1 | 0.98 | 0.13 | 0.95 | 1
|
| 31 | 1653 | peptide receptor activity | 0.008 | 0.16 | 0.74 | 1 | 0.98 | 0.14 | 0.96 | 1
|
| 32 | 8528 | peptide receptor activity, G-protein coupled | 0.008 | 0.16 | 0.74 | 1 | 0.98 | 0.14 | 0.96 | 1
|
| 33 | 9613 | response to pest/pathogen/parasite | 0.008 | 0.16 | 0.75 | 1 | 0.98 | 0.14 | 0.98 | 1
|
| 34 | 5179 | hormone activity | 0.009 | 0.16 | 0.77 | 1 | 0.99 | 0.14 | 0.99 | 1
|
| 35 | 45786 | negative regulation of cell cycle | 0.009 | 0.16 | 0.77 | 1 | 0.99 | 0.14 | 0.99 | 1
|
| 36 | 9605 | response to external stimulus | 0.009 | 0.16 | 0.77 | 1 | 0.99 | 0.14 | 0.99 | 1
|
| 37 | 4930 | G-protein coupled receptor activity | 0.01 | 0.16 | 0.78 | 1 | 0.99 | 0.15 | 1 | 1
|
| 38 | 6928 | cell motility | 0.01 | 0.17 | 0.81 | 1 | 0.99 | 0.17 | 1 | 1
|
| 39 | 8138 | protein tyrosine/serine/threonine phosphatase activity | 0.01 | 0.19 | 0.86 | 1 | 0.99 | 0.17 | 1 | 1
|
| 40 | 6695 | cholesterol biosynthesis | 0.01 | 0.19 | 0.86 | 1 | 0.99 | 0.17 | 1 | 1
|
| 41 | 16126 | sterol biosynthesis | 0.01 | 0.19 | 0.86 | 1 | 0.99 | 0.17 | 1 | 1
|
| 42 | 1558 | regulation of cell growth | 0.01 | 0.20 | 0.88 | 1 | 0.99 | 0.18 | 1 | 1
|
| 43 | 16049 | cell growth | 0.01 | 0.22 | 0.90 | 1 | 0.99 | 0.18 | 1 | 1
|
| 44 | 4888 | transmembrane receptor activity | 0.01 | 0.22 | 0.91 | 1 | 0.99 | 0.18 | 1 | 1
|
| 45 | 7610 | behavior | 0.02 | 0.24 | 0.93 | 1 | 1 | 0.18 | 1 | 1
|
| 46 | 50794 | regulation of cellular process | 0.02 | 0.24 | 0.93 | 1 | 1 | 0.18 | 1 | 1
|
| 47 | 4252 | serine-type endopeptidase activity | 0.02 | 0.24 | 0.94 | 1 | 1 | 0.18 | 1 | 1
|
| 48 | 30154 | cell differentiation | 0.02 | 0.24 | 0.94 | 1 | 1 | 0.18 | 1 | 1
|
| 49 | 5509 | calcium ion binding | 0.02 | 0.26 | 0.96 | 1 | 1 | 0.18 | 1 | 1
|
| 50 | 30097 | hemopoiesis | 0.02 | 0.28 | 0.97 | 1 | 1 | 0.18 | 1 | 1
|
| 51 | 7622 | rhythmic behavior | 0.02 | 0.28 | 0.97 | 1 | 1 | 0.18 | 1 | 1
|
| 52 | 8236 | serine-type peptidase activity | 0.02 | 0.29 | 0.97 | 1 | 1 | 0.18 | 1 | 1
|
| 53 | 1584 | rhodopsin-like receptor activity | 0.02 | 0.29 | 0.97 | 1 | 1 | 0.18 | 1 | 1
|
| 54 | 7242 | intracellular signaling cascade | 0.03 | 0.29 | 0.98 | 1 | 1 | 0.18 | 1 | 1
|
| 55 | 16477 | cell migration | 0.03 | 0.29 | 0.98 | 1 | 1 | 0.18 | 1 | 1
|
| 56 | 8150 | biological_process | 0.03 | 0.29 | 0.98 | 1 | 1 | 0.18 | 1 | 1
|
| 57 | 6959 | humoral immune response | 0.03 | 0.30 | 0.98 | 1 | 1 | 0.18 | 1 | 1
|
| 58 | 6694 | steroid biosynthesis | 0.03 | 0.30 | 0.98 | 1 | 1 | 0.18 | 1 | 1
|
| 59 | 46666 | retinal programmed cell death | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 60 | 8543 | FGF receptor signaling pathway | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 61 | 42136 | neurotransmitter biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 62 | 9241 | polyisoprenoid biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 63 | 16114 | terpenoid biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 64 | 16109 | tetraterpenoid biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 65 | 16117 | carotenoid biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 66 | 45210 | FasL biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 67 | 46246 | terpene biosynthesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 68 | 7406 | suppression of neuroblast proliferation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 69 | 16525 | negative regulation of angiogenesis | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 70 | 6890 | retrograde transport, Golgi to ER | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 71 | 86 | G2/M transition of mitotic cell cycle | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 72 | 16096 | polyisoprenoid metabolism | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 73 | 6721 | terpenoid metabolism | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 74 | 16108 | tetraterpenoid metabolism | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 75 | 16116 | carotenoid metabolism | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 76 | 45736 | negative regulation of CDK activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 77 | 79 | regulation of CDK activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 78 | 45666 | positive regulation of neuron differentiation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 79 | 45664 | regulation of neuron differentiation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 80 | 45445 | myoblast differentiation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 81 | 46652 | thymocyte differentiation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 82 | 904 | cellular morphogenesis during differentiation | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 83 | 46668 | regulation of retinal programmed cell death | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 84 | 4452 | isopentenyl-diphosphate delta-isomerase activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 85 | 8533 | astacin activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 86 | 4549 | tRNA-specific ribonuclease activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 87 | 4526 | ribonuclease P activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 88 | 16891 | endoribonuclease activity, producing 5'-phosphomonoesters | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 89 | 16529 | sarcoplasmic reticulum | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 90 | 5178 | integrin binding | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 91 | 16528 | sarcoplasm | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 92 | 19970 | interleukin-11 binding | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 93 | 4921 | interleukin-11 receptor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 94 | 4907 | interleukin receptor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 95 | 19965 | interleukin binding | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 96 | 4994 | somatostatin receptor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 97 | 16492 | neurotensin receptor activity, G-protein coupled | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 98 | 4983 | neuropeptide Y receptor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 99 | 16323 | basolateral plasma membrane | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 100 | 8188 | neuropeptide receptor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 101 | 42923 | neuropeptide binding | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 102 | 3823 | antigen binding | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 103 | 42214 | terpene metabolism | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 104 | 4351 | glutamate decarboxylase activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 105 | 16527 | brain-specific angiogenesis inhibitor activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 106 | 4367 | glycerol-3-phosphate dehydrogenase (NAD+) activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 107 | 3845 | 11-beta-hydroxysteroid dehydrogenase activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 108 | 4421 | hydroxymethylglutaryl-CoA synthase activity | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 109 | 6950 | response to stress | 0.03 | 0.52 | 0.99 | 1 | 1 | 0.18 | 1 | 1
|
| 110 | 8202 | steroid metabolism | 0.03 | 0.52 | 1 | 1 | 1 | 0.19 | 1 | 1
|
| 111 | 42277 | peptide binding | 0.04 | 0.53 | 1 | 1 | 1 | 0.21 | 1 | 1
|
| 112 | 7050 | cell cycle arrest | 0.04 | 0.53 | 1 | 1 | 1 | 0.21 | 1 | 1
|
| 113 | 16830 | carbon-carbon lyase activity | 0.05 | 0.56 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 114 | 16860 | intramolecular isomerase activity | 0.05 | 0.56 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 115 | 6936 | muscle contraction | 0.05 | 0.56 | 1 | 1 | 1 | 0.25 | 1 | 1
|
| 116 | 9100 | glycoprotein metabolism | 0.06 | 0.58 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 117 | 9101 | glycoprotein biosynthesis | 0.06 | 0.58 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 118 | 1525 | angiogenesis | 0.06 | 0.58 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 119 | 4175 | endopeptidase activity | 0.07 | 0.59 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 120 | 8203 | cholesterol metabolism | 0.07 | 0.59 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 121 | 16125 | sterol metabolism | 0.07 | 0.59 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 122 | 4332 | fructose-bisphosphate aldolase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 123 | 16832 | aldehyde-lyase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 124 | 42133 | neurotransmitter metabolism | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 125 | 15646 | permease activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 126 | 45597 | positive regulation of cell differentiation | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 127 | 8299 | isoprenoid biosynthesis | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 128 | 15563 | uptake permease activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 129 | 8889 | glycerophosphodiester phosphodiesterase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 130 | 7217 | tachykinin signaling pathway | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 131 | 1633 | secretin-like receptor activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 132 | 7548 | sex differentiation | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 133 | 186 | activation of MAPKK | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 134 | 42063 | gliogenesis | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 135 | 7529 | establishment of synaptic specificity at neuromuscular junction | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 136 | 7528 | neuromuscular junction development | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 137 | 4540 | ribonuclease activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 138 | 4864 | protein phosphatase inhibitor activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 139 | 19212 | phosphatase inhibitor activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 140 | 45765 | regulation of angiogenesis | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 141 | 10001 | glial cell differentiation | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 142 | 3828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 143 | 15406 | ABC-type uptake permease activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 144 | 19829 | cation-transporting ATPase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 145 | 3998 | acylphosphatase activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 146 | 4521 | endoribonuclease activity | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 147 | 9331 | glycerol-3-phosphate dehydrogenase complex | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 148 | 30424 | axon | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 149 | 5954 | calcium/calmodulin-dependent protein kinase complex | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 150 | 6957 | complement activation, alternative pathway | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 151 | 46821 | extrachromosomal DNA | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 152 | 5861 | troponin complex | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 153 | 5578 | extracellular matrix | 0.07 | 0.66 | 1 | 1 | 1 | 0.26 | 1 | 1
|
| 154 | 8369 | obsolete molecular function | 0.08 | 0.67 | 1 | 1 | 1 | 0.28 | 1 | 1
|
| 155 | 1568 | blood vessel development | 0.08 | 0.68 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 156 | 46872 | metal ion binding | 0.09 | 0.68 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 157 | 6066 | alcohol metabolism | 0.09 | 0.68 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 158 | 9611 | response to wounding | 0.09 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 159 | 7268 | synaptic transmission | 0.10 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 160 | 15035 | protein disulfide oxidoreductase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 161 | 6829 | zinc ion transport | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 162 | 30612 | arsenate reductase (thioredoxin) activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 163 | 43005 | neuronal cell projection | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 164 | 17157 | regulation of exocytosis | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 165 | 16228 | aldolase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 166 | 1654 | eye morphogenesis | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 167 | 4143 | diacylglycerol kinase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 168 | 3756 | protein disulfide isomerase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 169 | 16864 | intramolecular isomerase activity, transposing S-S bonds | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 170 | 16358 | dendrite morphogenesis | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 171 | 42552 | myelination | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 172 | 16229 | steroid dehydrogenase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 173 | 46912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 174 | 8207 | C21-steroid hormone metabolism | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 175 | 4861 | cyclin-dependent protein kinase inhibitor activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 176 | 43086 | negative regulation of enzyme activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 177 | 19840 | isoprenoid binding | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 178 | 5501 | retinoid binding | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 179 | 19841 | retinol binding | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 180 | 50790 | regulation of enzyme activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 181 | 42596 | fear response | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 182 | 30182 | neuron differentiation | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 183 | 5507 | copper ion binding | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 184 | 1662 | behavioral fear response | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 185 | 19233 | perception of pain | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 186 | 7193 | G-protein signaling, adenylate cyclase inhibiting pathway | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 187 | 16567 | protein ubiquitination | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 188 | 8217 | regulation of blood pressure | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 189 | 6700 | C21-steroid hormone biosynthesis | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 190 | 19955 | cytokine binding | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 191 | 30323 | respiratory tube development | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 192 | 30324 | lung development | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 193 | 16863 | intramolecular isomerase activity, transposing C=C bonds | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 194 | 6072 | glycerol-3-phosphate metabolism | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 195 | 42446 | hormone biosynthesis | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 196 | 16337 | cell-cell adhesion | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 197 | 19887 | protein kinase regulator activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 198 | 19207 | kinase regulator activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 199 | 3928 | RAB small monomeric GTPase activity | 0.11 | 0.69 | 1 | 1 | 1 | 0.29 | 1 | 1
|
| 200 | 19226 | transmission of nerve impulse | 0.11 | 0.69 | 1 | 1 | 1 | 0.30 | 1 | 1
|
| 201 | 7243 | protein kinase cascade | 0.12 | 0.71 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 202 | 74 | regulation of cell cycle | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 203 | 19751 | polyol metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 204 | 1608 | nucleotide receptor activity, G-protein coupled | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 205 | 6071 | glycerol metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 206 | 45595 | regulation of cell differentiation | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 207 | 165 | MAPKKK cascade | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 208 | 5865 | striated muscle thin filament | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 209 | 16764 | transferase activity, transferring other glycosyl groups | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 210 | 7623 | circadian rhythm | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 211 | 8373 | sialyltransferase activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 212 | 48193 | Golgi vesicle transport | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 213 | 82 | G1/S transition of mitotic cell cycle | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 214 | 8284 | positive regulation of cell proliferation | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 215 | 6638 | neutral lipid metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 216 | 3707 | steroid hormone receptor activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 217 | 7219 | N signaling pathway | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 218 | 6720 | isoprenoid metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 219 | 46486 | glycerolipid metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 220 | 7519 | myogenesis | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 221 | 16514 | SWI/SNF complex | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 222 | 4289 | subtilase activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 223 | 4685 | calcium/calmodulin-dependent protein kinase activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 224 | 5544 | calcium-dependent phospholipid binding | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 225 | 1614 | purinergic nucleotide receptor activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 226 | 6662 | glycerol ether metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 227 | 6639 | acylglycerol metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 228 | 30334 | regulation of cell migration | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 229 | 6641 | triacylglycerol metabolism | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 230 | 30098 | lymphocyte differentiation | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 231 | 16502 | nucleotide receptor activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 232 | 30611 | arsenate reductase activity | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 233 | 45028 | purinergic nucleotide receptor activity, G-protein coupled | 0.14 | 0.72 | 1 | 1 | 1 | 0.33 | 1 | 1
|
| 234 | 16829 | lyase activity | 0.15 | 0.72 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 235 | 45045 | secretory pathway | 0.15 | 0.72 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 236 | 5515 | protein binding | 0.15 | 0.72 | 1 | 1 | 1 | 0.34 | 1 | 1
|
| 237 | 7267 | cell-cell signaling | 0.15 | 0.73 | 1 | 1 | 1 | 0.35 | 1 | 1
|
| 238 | 7049 | cell cycle | 0.16 | 0.73 | 1 | 1 | 1 | 0.36 | 1 | 1
|
| 239 | 30484 | muscle fiber | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 240 | 4860 | protein kinase inhibitor activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 241 | 4879 | ligand-dependent nuclear receptor activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 242 | 16564 | transcriptional repressor activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 243 | 30017 | sarcomere | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 244 | 8366 | nerve ensheathment | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 245 | 42551 | nerve maturation | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 246 | 6968 | cellular defense response | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 247 | 19210 | kinase inhibitor activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 248 | 4683 | calmodulin regulated protein kinase activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 249 | 6084 | acetyl-CoA metabolism | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 250 | 30016 | myofibril | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 251 | 4519 | endonuclease activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 252 | 16459 | myosin | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 253 | 5884 | actin filament | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 254 | 4263 | chymotrypsin activity | 0.17 | 0.76 | 1 | 1 | 1 | 0.37 | 1 | 1
|
| 255 | 7399 | neurogenesis | 0.18 | 0.76 | 1 | 1 | 1 | 0.38 | 1 | 1
|
| 256 | 8283 | cell proliferation | 0.18 | 0.76 | 1 | 1 | 1 | 0.38 | 1 | 1
|
| 257 | 3700 | transcription factor activity | 0.19 | 0.76 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 258 | 5096 | GTPase activator activity | 0.19 | 0.76 | 1 | 1 | 1 | 0.39 | 1 | 1
|
| 259 | 5216 | ion channel activity | 0.19 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 260 | 50800 | hydrolase activity, acting on acid anhydrides, acting on GTP, involved in cellular and subcellular movement | 0.20 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 261 | 910 | cytokinesis | 0.20 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 262 | 15629 | actin cytoskeleton | 0.20 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 263 | 1503 | ossification | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 264 | 4295 | trypsin activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 265 | 7187 | G-protein signaling, coupled to cyclic nucleotide second messenger | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 266 | 1775 | cell activation | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 267 | 7188 | G-protein signaling, coupled to cAMP nucleotide second messenger | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 268 | 16831 | carboxy-lyase activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 269 | 45321 | immune cell activation | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 270 | 4896 | hematopoietin/interferon-class (D200-domain) cytokine receptor activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 271 | 19842 | vitamin binding | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 272 | 46649 | lymphocyte activation | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 273 | 15036 | disulfide oxidoreductase activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 274 | 41 | transition metal ion transport | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 275 | 5543 | phospholipid binding | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 276 | 8076 | voltage-gated potassium channel complex | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 277 | 16538 | cyclin-dependent protein kinase regulator activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 278 | 5391 | sodium/potassium-exchanging ATPase activity | 0.21 | 0.76 | 1 | 1 | 1 | 0.40 | 1 | 1
|
| 279 | 5886 | plasma membrane | 0.21 | 0.76 | 1 | 1 | 1 | 0.41 | 1 | 1
|
| 280 | 4857 | enzyme inhibitor activity | 0.23 | 0.78 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 281 | 15267 | channel/pore class transporter activity | 0.24 | 0.78 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 282 | 15268 | alpha-type channel activity | 0.24 | 0.78 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 283 | 6956 | complement activation | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 284 | 16064 | humoral defense mechanism (sensu Vertebrata) | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 285 | 1505 | regulation of neurotransmitter levels | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 286 | 6073 | glucan metabolism | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 287 | 5977 | glycogen metabolism | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 288 | 5581 | collagen | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 289 | 46849 | bone remodeling | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 290 | 6112 | energy reserve metabolism | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 291 | 42445 | hormone metabolism | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 292 | 4518 | nuclease activity | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 293 | 19208 | phosphatase regulator activity | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 294 | 19888 | protein phosphatase regulator activity | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 295 | 30020 | extracellular matrix structural constituent conferring tensile strength | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 296 | 6811 | ion transport | 0.24 | 0.79 | 1 | 1 | 1 | 0.43 | 1 | 1
|
| 297 | 7264 | small GTPase mediated signal transduction | 0.24 | 0.79 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 298 | 30234 | enzyme regulator activity | 0.25 | 0.79 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 299 | 6629 | lipid metabolism | 0.25 | 0.79 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 300 | 6813 | potassium ion transport | 0.25 | 0.79 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 301 | 5941 | unlocalized | 0.25 | 0.79 | 1 | 1 | 1 | 0.44 | 1 | 1
|
| 302 | 3925 | small monomeric GTPase activity | 0.26 | 0.79 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 303 | 5516 | calmodulin binding | 0.26 | 0.79 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 304 | 8083 | growth factor activity | 0.26 | 0.79 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 305 | 7229 | integrin-mediated signaling pathway | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 306 | 19935 | cyclic-nucleotide-mediated signaling | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 307 | 19933 | cAMP-mediated signaling | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 308 | 6954 | inflammatory response | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 309 | 45087 | innate immune response | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 310 | 16585 | chromatin remodeling complex | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 311 | 5976 | polysaccharide metabolism | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 312 | 7420 | brain development | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 313 | 30001 | metal ion transport | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 314 | 8233 | peptidase activity | 0.27 | 0.80 | 1 | 1 | 1 | 0.46 | 1 | 1
|
| 315 | 6457 | protein folding | 0.28 | 0.80 | 1 | 1 | 1 | 0.47 | 1 | 1
|
| 316 | 16616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.28 | 0.80 | 1 | 1 | 1 | 0.47 | 1 | 1
|
| 317 | 30528 | transcription regulator activity | 0.28 | 0.80 | 1 | 1 | 1 | 0.48 | 1 | 1
|
| 318 | 5201 | extracellular matrix structural constituent | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 319 | 19932 | second-messenger-mediated signaling | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 320 | 16917 | GABA receptor activity | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 321 | 7266 | Rho protein signal transduction | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 322 | 7214 | gamma-aminobutyric acid signaling pathway | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 323 | 7157 | heterophilic cell adhesion | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 324 | 4890 | GABA-A receptor activity | 0.29 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 325 | 3924 | GTPase activity | 0.30 | 0.82 | 1 | 1 | 1 | 0.49 | 1 | 1
|
| 326 | 16614 | oxidoreductase activity, acting on CH-OH group of donors | 0.30 | 0.83 | 1 | 1 | 1 | 0.50 | 1 | 1
|
| 327 | 8047 | enzyme activator activity | 0.30 | 0.83 | 1 | 1 | 1 | 0.50 | 1 | 1
|
| 328 | 4222 | metalloendopeptidase activity | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 329 | 6486 | protein amino acid glycosylation | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 330 | 8015 | circulation | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 331 | 6887 | exocytosis | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 332 | 8081 | phosphoric diester hydrolase activity | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 333 | 7160 | cell-matrix adhesion | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 334 | 45892 | negative regulation of transcription, DNA-dependent | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 335 | 5834 | heterotrimeric G-protein complex | 0.32 | 0.85 | 1 | 1 | 1 | 0.51 | 1 | 1
|
| 336 | 6812 | cation transport | 0.33 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 337 | 5200 | structural constituent of cytoskeleton | 0.33 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 338 | 8610 | lipid biosynthesis | 0.33 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 339 | 6470 | protein amino acid dephosphorylation | 0.33 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 340 | 42578 | phosphoric ester hydrolase activity | 0.34 | 0.85 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 341 | 42995 | cell projection | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 342 | 4177 | aminopeptidase activity | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 343 | 30246 | carbohydrate binding | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 344 | 5529 | sugar binding | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 345 | 7600 | sensory perception | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 346 | 5262 | calcium channel activity | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 347 | 7626 | locomotory behavior | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 348 | 7417 | central nervous system development | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 349 | 6814 | sodium ion transport | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 350 | 287 | magnesium ion binding | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 351 | 16311 | dephosphorylation | 0.35 | 0.86 | 1 | 1 | 1 | 0.53 | 1 | 1
|
| 352 | 5488 | binding | 0.36 | 0.86 | 1 | 1 | 1 | 0.54 | 1 | 1
|
| 353 | 30594 | neurotransmitter receptor activity | 0.37 | 0.88 | 1 | 1 | 1 | 0.56 | 1 | 1
|
| 354 | 42165 | neurotransmitter binding | 0.37 | 0.88 | 1 | 1 | 1 | 0.56 | 1 | 1
|
| 355 | 5261 | cation channel activity | 0.38 | 0.88 | 1 | 1 | 1 | 0.57 | 1 | 1
|
| 356 | 6725 | aromatic compound metabolism | 0.40 | 0.90 | 1 | 1 | 1 | 0.59 | 1 | 1
|
| 357 | 1501 | skeletal development | 0.40 | 0.90 | 1 | 1 | 1 | 0.59 | 1 | 1
|
| 358 | 9581 | perception of external stimulus | 0.40 | 0.90 | 1 | 1 | 1 | 0.59 | 1 | 1
|
| 359 | 4721 | phosphoprotein phosphatase activity | 0.40 | 0.90 | 1 | 1 | 1 | 0.60 | 1 | 1
|
| 360 | 16853 | isomerase activity | 0.40 | 0.90 | 1 | 1 | 1 | 0.60 | 1 | 1
|
| 361 | 42598 | vesicular fraction | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 362 | 42127 | regulation of cell proliferation | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 363 | 5792 | microsome | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 364 | 5249 | voltage-gated potassium channel activity | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 365 | 6821 | chloride transport | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 366 | 16481 | negative regulation of transcription | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 367 | 16788 | hydrolase activity, acting on ester bonds | 0.42 | 0.91 | 1 | 1 | 1 | 0.61 | 1 | 1
|
| 368 | 5887 | integral to plasma membrane | 0.43 | 0.91 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 369 | 19897 | extrinsic to plasma membrane | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 370 | 19898 | extrinsic to membrane | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 371 | 3927 | heterotrimeric G-protein GTPase activity | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 372 | 87 | M phase of mitotic cell cycle | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 373 | 7067 | mitosis | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 374 | 8021 | synaptic vesicle | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 375 | 15674 | di-, tri-valent inorganic cation transport | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 376 | 16787 | hydrolase activity | 0.44 | 0.92 | 1 | 1 | 1 | 0.63 | 1 | 1
|
| 377 | 5230 | extracellular ligand-gated ion channel activity | 0.46 | 0.93 | 1 | 1 | 1 | 0.65 | 1 | 1
|
| 378 | 7169 | transmembrane receptor protein tyrosine kinase signaling pathway | 0.46 | 0.93 | 1 | 1 | 1 | 0.65 | 1 | 1
|
| 379 | 902 | cellular morphogenesis | 0.46 | 0.93 | 1 | 1 | 1 | 0.65 | 1 | 1
|
| 380 | 15980 | energy derivation by oxidation of organic compounds | 0.48 | 0.94 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 381 | 6091 | energy pathways | 0.48 | 0.94 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 382 | 4009 | ATP-binding cassette (ABC) transporter activity | 0.48 | 0.95 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 383 | 15698 | inorganic anion transport | 0.48 | 0.95 | 1 | 1 | 1 | 0.68 | 1 | 1
|
| 384 | 5856 | cytoskeleton | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 385 | 5777 | peroxisome | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 386 | 8238 | exopeptidase activity | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 387 | 8201 | heparin binding | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 388 | 280 | nuclear division | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 389 | 42579 | microbody | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 390 | 279 | M phase | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 391 | 6096 | glycolysis | 0.50 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 392 | 30695 | GTPase regulator activity | 0.51 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 393 | 16192 | vesicle-mediated transport | 0.51 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 394 | 16817 | hydrolase activity, acting on acid anhydrides | 0.51 | 0.96 | 1 | 1 | 1 | 0.69 | 1 | 1
|
| 395 | 6508 | proteolysis and peptidolysis | 0.52 | 0.96 | 1 | 1 | 1 | 0.70 | 1 | 1
|
| 396 | 278 | mitotic cell cycle | 0.52 | 0.96 | 1 | 1 | 1 | 0.70 | 1 | 1
|
| 397 | 5198 | structural molecule activity | 0.53 | 0.97 | 1 | 1 | 1 | 0.71 | 1 | 1
|
| 398 | 5975 | carbohydrate metabolism | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 399 | 5525 | GTP binding | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 400 | 19001 | guanyl nucleotide binding | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 401 | 15276 | ligand-gated ion channel activity | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 402 | 5267 | potassium channel activity | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 403 | 6333 | chromatin assembly/disassembly | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 404 | 5539 | glycosaminoglycan binding | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 405 | 16791 | phosphoric monoester hydrolase activity | 0.54 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 406 | 5624 | membrane fraction | 0.55 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 407 | 30163 | protein catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 408 | 46365 | monosaccharide catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 409 | 19320 | hexose catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 410 | 6007 | glucose catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 411 | 30136 | clathrin-coated vesicle | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 412 | 46164 | alcohol catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.72 | 1 | 1
|
| 413 | 9057 | macromolecule catabolism | 0.56 | 0.97 | 1 | 1 | 1 | 0.73 | 1 | 1
|
| 414 | 6512 | ubiquitin cycle | 0.58 | 0.98 | 1 | 1 | 1 | 0.74 | 1 | 1
|
| 415 | 16052 | carbohydrate catabolism | 0.59 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 416 | 30135 | coated vesicle | 0.59 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 417 | 4725 | protein-tyrosine-phosphatase activity | 0.59 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 418 | 8237 | metallopeptidase activity | 0.59 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 419 | 5489 | electron transporter activity | 0.60 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 420 | 5871 | kinesin complex | 0.60 | 0.99 | 1 | 1 | 1 | 0.76 | 1 | 1
|
| 421 | 3774 | motor activity | 0.61 | 0.99 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 422 | 6006 | glucose metabolism | 0.61 | 0.99 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 423 | 5575 | cellular_component | 0.61 | 0.99 | 1 | 1 | 1 | 0.77 | 1 | 1
|
| 424 | 5244 | voltage-gated ion channel activity | 0.62 | 0.99 | 1 | 1 | 1 | 0.78 | 1 | 1
|
| 425 | 6355 | regulation of transcription, DNA-dependent | 0.63 | 0.99 | 1 | 1 | 1 | 0.79 | 1 | 1
|
| 426 | 15672 | monovalent inorganic cation transport | 0.63 | 0.99 | 1 | 1 | 1 | 0.79 | 1 | 1
|
| 427 | 5794 | Golgi apparatus | 0.63 | 0.99 | 1 | 1 | 1 | 0.79 | 1 | 1
|
| 428 | 267 | cell fraction | 0.64 | 0.99 | 1 | 1 | 1 | 0.80 | 1 | 1
|
| 429 | 45449 | regulation of transcription | 0.65 | 0.99 | 1 | 1 | 1 | 0.80 | 1 | 1
|
| 430 | 6820 | anion transport | 0.65 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 431 | 46914 | transition metal ion binding | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 432 | 6351 | transcription, DNA-dependent | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 433 | 5996 | monosaccharide metabolism | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 434 | 8289 | lipid binding | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 435 | 16746 | transferase activity, transferring acyl groups | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 436 | 19318 | hexose metabolism | 0.66 | 0.99 | 1 | 1 | 1 | 0.81 | 1 | 1
|
| 437 | 5730 | nucleolus | 0.68 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 438 | 42625 | ATPase activity, coupled to transmembrane movement of ions | 0.68 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 439 | 15662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism | 0.68 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 440 | 15891 | siderochrome transport | 0.68 | 0.99 | 1 | 1 | 1 | 0.82 | 1 | 1
|
| 441 | 5875 | microtubule associated complex | 0.69 | 0.99 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 442 | 6974 | response to DNA damage stimulus | 0.69 | 0.99 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 443 | 9719 | response to endogenous stimulus | 0.69 | 0.99 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 444 | 9056 | catabolism | 0.69 | 0.99 | 1 | 1 | 1 | 0.83 | 1 | 1
|
| 445 | 8324 | cation transporter activity | 0.71 | 0.99 | 1 | 1 | 1 | 0.85 | 1 | 1
|
| 446 | 7582 | physiological process | 0.72 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 447 | 6350 | transcription | 0.72 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 448 | 16757 | transferase activity, transferring glycosyl groups | 0.72 | 0.99 | 1 | 1 | 1 | 0.86 | 1 | 1
|
| 449 | 5654 | nucleoplasm | 0.74 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 450 | 6732 | coenzyme metabolism | 0.74 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 451 | 8270 | zinc ion binding | 0.74 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 452 | 12501 | programmed cell death | 0.74 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 453 | 6092 | main pathways of carbohydrate metabolism | 0.75 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 454 | 7167 | enzyme linked receptor protein signaling pathway | 0.75 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 455 | 3779 | actin binding | 0.75 | 0.99 | 1 | 1 | 1 | 0.87 | 1 | 1
|
| 456 | 8151 | cell growth and/or maintenance | 0.75 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 457 | 6325 | establishment and/or maintenance of chromatin architecture | 0.75 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 458 | 5840 | ribosome | 0.76 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 459 | 15075 | ion transporter activity | 0.76 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 460 | 8219 | cell death | 0.76 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 461 | 6464 | protein modification | 0.76 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 462 | 16021 | integral to membrane | 0.76 | 0.99 | 1 | 1 | 1 | 0.88 | 1 | 1
|
| 463 | 16265 | death | 0.77 | 0.99 | 1 | 1 | 1 | 0.89 | 1 | 1
|
| 464 | 16301 | kinase activity | 0.78 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 465 | 6520 | amino acid metabolism | 0.78 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 466 | 16023 | cytoplasmic vesicle | 0.78 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 467 | 7001 | chromosome organization and biogenesis (sensu Eukarya) | 0.79 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 468 | 3674 | molecular_function | 0.79 | 0.99 | 1 | 1 | 1 | 0.90 | 1 | 1
|
| 469 | 16818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 0.80 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 470 | 15630 | microtubule cytoskeleton | 0.80 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 471 | 6118 | electron transport | 0.80 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 472 | 6412 | protein biosynthesis | 0.80 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 473 | 6323 | DNA packaging | 0.81 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 474 | 16020 | membrane | 0.81 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 475 | 6731 | coenzyme and prosthetic group metabolism | 0.81 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 476 | 5667 | transcription factor complex | 0.81 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 477 | 6796 | phosphate metabolism | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 478 | 6793 | phosphorus metabolism | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 479 | 6997 | nuclear organization and biogenesis | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 480 | 42626 | ATPase activity, coupled to transmembrane movement of substances | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 481 | 16820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 482 | 3735 | structural constituent of ribosome | 0.82 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 483 | 5783 | endoplasmic reticulum | 0.83 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 484 | 5215 | transporter activity | 0.83 | 0.99 | 1 | 1 | 1 | 0.91 | 1 | 1
|
| 485 | 9059 | macromolecule biosynthesis | 0.83 | 0.99 | 1 | 1 | 1 | 0.92 | 1 | 1
|
| 486 | 19538 | protein metabolism | 0.85 | 0.99 | 1 | 1 | 1 | 0.93 | 1 | 1
|
| 487 | 3754 | chaperone activity | 0.85 | 0.99 | 1 | 1 | 1 | 0.93 | 1 | 1
|
| 488 | 9058 | biosynthesis | 0.86 | 0.99 | 1 | 1 | 1 | 0.94 | 1 | 1
|
| 489 | 8092 | cytoskeletal protein binding | 0.86 | 0.99 | 1 | 1 | 1 | 0.94 | 1 | 1
|
| 490 | 6519 | amino acid and derivative metabolism | 0.87 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 491 | 3677 | DNA binding | 0.87 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 492 | 15405 | P-P-bond-hydrolysis-driven transporter activity | 0.88 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 493 | 8565 | protein transporter activity | 0.88 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 494 | 6259 | DNA metabolism | 0.88 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 495 | 16491 | oxidoreductase activity | 0.89 | 0.99 | 1 | 1 | 1 | 0.95 | 1 | 1
|
| 496 | 9308 | amine metabolism | 0.89 | 0.99 | 1 | 1 | 1 | 0.96 | 1 | 1
|
| 497 | 16773 | phosphotransferase activity, alcohol group as acceptor | 0.90 | 0.99 | 1 | 1 | 1 | 0.97 | 1 | 1
|
| 498 | 4674 | protein serine/threonine kinase activity | 0.91 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 499 | 6468 | protein amino acid phosphorylation | 0.92 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 500 | 7010 | cytoskeleton organization and biogenesis | 0.92 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 501 | 42623 | ATPase activity, coupled | 0.92 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 502 | 30529 | ribonucleoprotein complex | 0.92 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 503 | 6915 | apoptosis | 0.93 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 504 | 16887 | ATPase activity | 0.93 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 505 | 16310 | phosphorylation | 0.93 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 506 | 4672 | protein kinase activity | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 507 | 5634 | nucleus | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 508 | 5524 | ATP binding | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 509 | 30554 | adenyl nucleotide binding | 0.94 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 510 | 3824 | catalytic activity | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 511 | 6082 | organic acid metabolism | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 512 | 19752 | carboxylic acid metabolism | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 513 | 15399 | primary active transporter activity | 0.95 | 0.99 | 1 | 1 | 1 | 0.98 | 1 | 1
|
| 514 | 17076 | purine nucleotide binding | 0.95 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 515 | 166 | nucleotide binding | 0.95 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 516 | 6886 | intracellular protein transport | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 517 | 6996 | organelle organization and biogenesis | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 518 | 16043 | cell organization and biogenesis | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 519 | 4713 | protein-tyrosine kinase activity | 0.96 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 520 | 15031 | protein transport | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 521 | 6810 | transport | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 522 | 6139 | nucleobase, nucleoside, nucleotide and nucleic acid metabolism | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 523 | 16772 | transferase activity, transferring phosphorus-containing groups | 0.97 | 0.99 | 1 | 1 | 1 | 0.99 | 1 | 1
|
| 524 | 46907 | intracellular transport | 0.98 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 525 | 5386 | carrier activity | 0.98 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 526 | 16740 | transferase activity | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 527 | 8152 | metabolism | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 528 | 7028 | cytoplasm organization and biogenesis | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 529 | 5623 | cell | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 530 | 3676 | nucleic acid binding | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 531 | 5737 | cytoplasm | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 532 | 5622 | intracellular | 0.99 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|
| 533 | 3673 | Gene_Ontology | 1 | 0.99 | 1 | 1 | 1 | 1 | 1 | 1
|